Please use this identifier to cite or link to this item: doi:10.22028/D291-36798
Volltext verfügbar? / Dokumentlieferung
Title: Time-updated resting heart rate predicts mortality in patients with COPD
Author(s): Omlor, Albert J.
Trudzinski, Franziska C.
Alqudrah, Mohamad
Seiler, Frederik
Biertz, Frank
Vogelmeier, Claus F.
Welte, Tobias
Watz, Henrik
Waschki, Benjamin
Brinker, Titus J.
Andreas, Stefan
Fähndrich, Sebastian
Alter, Peter
Jörres, Rudolf A.
Böhm, Michael
Bals, Robert
Language: English
Title: Clinical Research in Cardiology
Volume: 109
Issue: 6
Pages: 776–786
Publisher/Platform: Springer Nature
Year of Publication: 2019
Free key words: COSYCONET
COPD
Heart rate
Comorbidity
Mortality
DDC notations: 610 Medicine and health
Publikation type: Journal Article
Abstract: High resting heart rate (RHR) is associated with higher mortality in the general population and in cardiovascular disease. Less is known about the association of RHR with outcome in chronic obstructive pulmonary disease (COPD). In particular, the time-updated RHR (most recent value before the event) appears informative. This is the first study to investigate the association of time-updated RHR with mortality in COPD. We compared the baseline and time-updated RHR related to survival in 2218 COPD patients of the German COSYCONET cohort (COPD and Systemic Consequences—Comorbidities Network). Patients with a baseline RHR > 72 beats per minute (bmp) had a significantly (p = 0.049) higher all-cause mortality risk (adjusted hazard ratio (HR) of 1.37 (1.00–1.87) compared to baseline RHR ≤ 72 bpm. The time-updated RHR > 72 bpm was markedly superior (HR 1.79, 1.30–2.46, p = 0.001). Both, increased baseline and time-updated RHR, were independently associated with low FEV1, low TLCO, a history of diabetes, and medication with short-acting beta agonists (SABAs). In conclusion, increased time-updated RHR is associated with higher mortality in COPD independent of other predictors and superior to baseline RHR. Increased RHR is linked to lung function, comorbidities and medication. Whether RHR is an effective treatment target in COPD, needs to be proven in controlled trials.
DOI of the first publication: 10.1007/s00392-019-01572-1
URL of the first publication: https://link.springer.com/article/10.1007/s00392-019-01572-1
Link to this record: urn:nbn:de:bsz:291--ds-367982
hdl:20.500.11880/33433
http://dx.doi.org/10.22028/D291-36798
ISSN: 1861-0692
1861-0684
Date of registration: 13-Jul-2022
Faculty: M - Medizinische Fakultät
Department: M - Innere Medizin
Professorship: M - Prof. Dr. Robert Bals
M - Prof. Dr. Michael Böhm
Collections:SciDok - Der Wissenschaftsserver der Universität des Saarlandes

Files for this record:
There are no files associated with this item.


Items in SciDok are protected by copyright, with all rights reserved, unless otherwise indicated.